Ventilatory efficiency testing as prognostic value in patients with pulmonary hypertension

BMC Pulmonary Medicine

Volumn 12, Issue , 2012, Pages

  Schwaiblmair, Martin ^a   Faul, Christian ^a   von Scheidt, Wolfgang ^a   Berghaus, Thomas M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CARBON DIOXIDE; ENDOTHELIN RECEPTOR ANTAGONIST; OXYGEN; PHOSPHODIESTERASE V INHIBITOR; PROSTANOID;

ADULT; AGED; ANAEROBIC THRESHOLD; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART INDEX; HEART RIGHT ATRIUM PRESSURE; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OXYGEN CONSUMPTION; PREDICTIVE VALUE; PROGNOSIS; PULMONARY HYPERTENSION; RISK ASSESSMENT; SURVIVOR; WORK CAPACITY;

AGED; CARDIAC CATHETERIZATION; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; LINEAR MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY VENTILATION; RESPIRATORY FUNCTION TESTS; SURVIVAL ANALYSIS;

EID: 84861892367     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-12-23     Document Type: Article

References (46)

1. Oudiz R, Barst R, Hansen J, et al. Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. Am J Cardiol 2006, 97:123-126. 10.1016/j.amjcard.2005.07.129, 16377296.
2. Wensel R, Opitz C, Anker S, et al. Assessment of survival in patients with primary pulmonary hypertension. Importance of cardiopulmonary exercise testing. Circulation 2002, 106:319-324. 10.1161/01.CIR.0000022687.18568.2A, 12119247.
3. Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. A, J Respir Crit Care Med 2000, 161:487-492.
4. Riley M, Porszasz J, Engelen M, Brundage B, Wasserman K. Gas exchange responses to continuous incremental cycle ergometry exercise in primary pulmonary hypertension in humans. Eur J Appl Physiol 2000, 83:63-70. 10.1007/s004210000240, 11072775.
5. Sun X, Hansen J, Oudiz R, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001, 104:429-435. 10.1161/hc2901.093198, 11468205.
6. Sun X, Hansen J, Oudiz R, Wasserman K. Gas exchange detection of exercise-induced right-to-left shunt in patients with primary pulmonary hypertension. Circulation 2002, 105:54-60. 10.1161/hc0102.101509, 11772876.
7. Hansen J, Sun X, Yasunobu Y, et al. Reproducibility of cardiopulmonary exercise measurements in patients with pulmonary arterial hypertension. Chest 2004, 126:816-824. 10.1378/chest.126.3.816, 15364761.
8. Markowitz D, Systrom D. Diagnosis of pulmonary vascular limit to exercise by cardiopulmonary exercise testing. J Heart Lung Trans 2004, 23:88-95.
9. Nagaya N, Shimizu Y, Satoh T, et al. Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension. Heart 2002, 87:340-345. 10.1136/heart.87.4.340, 1767070, 11907007.
10. Yasunobu Y, Oudiz R, Sun X, Hansen J, Wasserman K. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest 2005, 127:1637-1646. 10.1378/chest.127.5.1637, 15888840.
11. Reindl I, Wernecke K, Opitz C, et al. Impaired ventilatory efficiency in chronic heart failure: possible role of pulmonary vasoconstriction. Am Heart J 1998, 136:778-785. 10.1016/S0002-8703(98)70121-8, 9812071.
12. Lewis N, Banning A, Cooper J, et al. Impaired matching of perfusion and ventilation in heart failure detected by 133xenon. Basic Res Cardiol 1996, 91(suppl 1):45-49.
13. Arena R, Myers J, Aslam S, Varughese E, Peberdy M. Peak VO2 and VE/VCO2 slope in patients with heart failure: A prognostic comparison. Am Heart J 2004, 147:354-360. 10.1016/j.ahj.2003.07.014, 14760336.
14. Chua T, Ponikowski P, Harrington D, et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997, 29:1585-1590. 10.1016/S0735-1097(97)00078-8, 9180123.
15. Kleber F, Vietzke G, Wernecke K, et al. Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation 2000, 101:2803-2809. 10.1161/01.CIR.101.24.2803, 10859285.
16. Francis D, Shamim W, Davies L, et al. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2) slope and peak VO(2). Eur Heart J 2000, 21:154-161. 10.1053/euhj.1999.1863, 10637089.
17. Davies L, Francis D, Piepoli M, Scott A, Ponikowski P, Coats A. Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification. Heart 2000, 83:147-151. 10.1136/heart.83.2.147, 1729303, 10648485.
18. Corra U, Mezzani A, Bosimini E, Scapellato F, Imparato A, Giannuzzi P. Ventilatory response to exercise improves risk stratification in patients with chronic heart failure and intermediate functional capacity. Am Heart J 2002, 143:418-426. 10.1067/mhj.2002.120772, 11868046.
19. Gitt A, Wasserman K, Kilkowski C, et al. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation 2002, 106:3079-3084. 10.1161/01.CIR.0000041428.99427.06, 12473555.
20. Witte K, Thackray S, Nikitin N, Cleland J, Clark A. Pattern of ventilation during exercise in chronic heart failure. Heart 2003, 89:610-614. 10.1136/heart.89.6.610, 1767691, 12748213.
21. Guazzi M, Myers J, Arena R. Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure. J Am Coll Cardiol 2005, 46:1883-1890. 10.1016/j.jacc.2005.07.051, 16286176.
22. Guazzi M, Raimondo R, Vicenzi M, et al. Exercise oscillatory ventilation may predict sudden cardiac death in heart failure patients. J Am Coll Cardiol 2007, 50:299-308. 10.1016/j.jacc.2007.03.042, 17659196.
23. Ting H, Sun X, Chuang M, Lewis D, Hansen J, Wasserman K. A noninvasive assessment of pulmonary perfusion abnormality in patients with primary pulmonary hypertension. Chest 2001, 119:824-832. 10.1378/chest.119.3.824, 11243964.
24. Reybrouck T, Mertens L, Schulze-Neick I, et al. Ventilatory inefficiency for carbon dioxide during exercise in patients with pulmonary hypertension. Clin Physiol 2008, 28:337-344.
25. Mitani R, Haraguchi M, Takata S, et al. Excessive ventilatory response during exercise in patients with non-hypoxic pulmonary hypertension. Circ J 2002, 66:453-456. 10.1253/circj.66.453, 12030339.
26. Humbert M, McLaughlin V. Proceedings of the 4th World Symposium on Pulmonary Hypertension. J Am Coll Cardiol 2009, 54:S1-S116. 10.1016/j.jacc.2009.04.013, 19630151.
27. ESC/ERS Guidelines Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2009, 30:2493-2537. ESC/ERS Guidelines.
28. Quanjer P, Tammeling G, Cotes J, et al. Lung volumes and forced ventilatory flows: Report Working Party Standardization of Lung Function Tests; European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993, 16:5-40.
29. McEvoy J, Jones N. Arterialized capillary blood gases in exercise studies. Med Sci Sports 1975, 7:312-315.
30. American Thoracic Society Guidelines for the six-minute walk test. ATS statement. Am J Respir Crit Care Med 2002, 166:111-117. American Thoracic Society.
31. Wasserman K, Hansen J, Sue D, Stringer W, Whipp B. Principles of Exercise Testing and Interpretation 2004, Lippincott Williams & Wilkens, Baltimore, MD, 4.
32. Fukuchi K, Hayashida K, Nakanishi N, et al. Quantitative analysis of lung perfusion in patients with primary pulmonary hypertension. J Nucl Med 2002, 43:757-761.
33. Tabet J, Beauvais F, Thabut G, Tartiere J-M, Logeart D, Cohen-Solal A. A critical appraisal of the prognostic value of the VE/VCO2 slope in chronic heart failure. Eur J Cardiovasc Prev Reha 2003, 10:267-272.
34. Guazzi M, de Vita S, Cardano P, Barlera S, Guazzi M. Normalization for peak oxygen uptake increases the prognostic power of the ventilatory response to exercise in patients with chronic heart failure. Am Heart J 2003, 146:542-548. 10.1016/S0002-8703(03)00321-1, 12947376.
35. Nanas S, Nanas J, Sakellariou D, et al. Ve/VCO2 slope is associated with abnormal resting haemodynamics and is a predictor of long-term survival in chronic heart failure. Eur J Heart Fail 2006, 8:420-427. 10.1016/j.ejheart.2005.10.003, 16310408.
36. Wasserman K, Zhang Y, Gitt A, et al. Lung function and exercise gas exchange in chronic heart failure. Circulation 1997, 96:2221-2227. 10.1161/01.CIR.96.7.2221, 9337193.
37. Wada O, Asanoi H, Miyagi K, et al. Importance of abnormal lung perfusion in excessive exercise ventilation in chronic heart failure. Am Heart J 1993, 125:790-798. 10.1016/0002-8703(93)90173-7, 8438708.
38. Puri S, Baker B, Oakley C, Hughes J, Cleland J. Increased alveolar/capillary membrane resistance to gas transfer in patients with chronic heart failure. Br Heart J 1994, 72:140-144. 10.1136/hrt.72.2.140, 1025477, 7917686.
39. Daganou M, Dimopoulou I, Alivizatos P, Tzelepis G. Pulmonary function and respiratory muscle strength in chronic heart failure: comparison between ischaemic and idiopathic dilated cardiomyopathy. Heart 1999, 81:618-620. 1729061, 10336921.
40. Chua T, Clark A, Amadi A, Coats A. Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1996, 27:650-657. 10.1016/0735-1097(95)00523-4, 8606277.
41. Narkiewicz K, Pesek C, van de Borne P, Kato M, Somers V. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 1999, 100:262-267. 10.1161/01.CIR.100.3.262, 10411850.
42. Johnson R. Gas exchange efficiency in congestive heart failure. Circulation 2000, 101:2774-2776. 10.1161/01.CIR.101.24.2774, 10859280.
43. Ukkonen H, Burwash I, Dafoe W, et al. Is ventilatory efficiency (VE/VCO2 slope) associated with right ventricular oxidative metabolism in patients with congestive heart failure. Eur J Heart Fail 2008, 10:1117-1122. 10.1016/j.ejheart.2008.08.010, 18818123.
44. Arzt M, Harth M, Luchner A, et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and central sleep apnea. Circulation 2003, 107:1998-2003. 10.1161/01.CIR.0000065227.04025.C2, 12695297.
45. Habedank D, Reindl I, Vietzke G, Bauer U, Sperfeld A. Ventilatory efficiency and exercise tolerance in 101 healthy volunteers. Eur J Appl Physiol 1998, 77:412-426.
46. Van Laethem C, Bartunek J, Goethals M, Nellens P, Andries E, Vanderheyden M. Oxygen uptake efficiency slope, a new submaximal parameter in evaluating exercise capacity in chronic heart failure patients. Am Heart J 2005, 149:175-180. 10.1016/j.ahj.2004.07.004, 15660050.